Filing Details
- Accession Number:
- 0001144204-18-019836
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-09 19:36:47
- Reporting Period:
- 2018-04-09
- Accepted Time:
- 2018-04-09 19:36:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1270073 | Intercept Pharmaceuticals Inc | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559569 | Mark Pruzanski | C/O Intercept Pharmaceuticals, Inc., 10 Hudson Yards, Floor 37 New York NY 10001 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-04-09 | 7,812 | $64.00 | 576,564 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
